Protocol Name: AZURE: Effect of AZD0780 on Major Adverse Cardiovascular Events in Patients with Established Atherosclerotic Cardiovascular Disease (ASCVD) or at High Risk for a First ASCVD Event
Protocol #: D7960C00015
Indication: Cardiovascular Event Risk Reduction
GFR: ≥15
Principal Investigator: Ankit N. Mehta, MD, FASN
Location: Landry Center, 411 N. Washington Ave, Suite #6000, Dallas, TX 75246